Retatrutide, a experimental dual stimulator of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) target, is exhibiting promising results in initial clinical trials . Current research https://seolistlinks.com/story22882641/retatrutide-emerging-research-and-projected-clinical-uses